Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Charles River Laboratories International, Inc. Common Stock
(NY:
CRL
)
163.36
+13.57 (+9.06%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 22, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Charles River Laboratories International, Inc. Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Uncover the latest developments among S&P500 stocks in today's session.
February 24, 2025
Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top S&P500 gainers and losers in today's session.
Via
Chartmill
Exploring the top movers within the S&P500 index during today's session.
February 24, 2025
Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.
Via
Chartmill
UFP Technologies (UFPT) Reports Q4: Everything You Need To Know Ahead Of Earnings
February 24, 2025
Medical products company UFP Technologies (NASDAQ:UFPT) will be announcing earnings results tomorrow morning. Here’s what to look for.
Via
StockStory
Analyst Sees Charles River As Preclinical Leader But Maintains Neutral Stance
February 19, 2025
Charles River's Q4 revenue topped estimates despite a 1.1% decline. The company forecasts a revenue drop in 2025, with biotech demand expected to stabilize.
Via
Benzinga
Earnings Scheduled For February 19, 2025
February 19, 2025
Via
Benzinga
Analyst Expectations For Charles River's Future
February 18, 2025
Via
Benzinga
What Analysts Are Saying About Charles River Stock
January 23, 2025
Via
Benzinga
Which S&P500 stocks are moving on Wednesday?
February 19, 2025
Let's delve into the developments on the US markets one hour before the close of the markets on Wednesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.
Via
Chartmill
In today's session, there are S&P500 stocks with remarkable trading volume.
February 19, 2025
Curious about which S&P500 stocks are generating unusual volume on Wednesday? Find out below.
Via
Chartmill
What's going on in today's session: S&P500 movers
February 19, 2025
Stay informed about the performance of the S&P500 index in the middle of the day on Wednesday. Uncover the top gainers and losers in today's session for valuable insights.
Via
Chartmill
Earnings To Watch: Repligen (RGEN) Reports Q4 Results Tomorrow
February 19, 2025
Biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) will be announcing earnings results tomorrow morning. Here’s what you need to know.
Via
StockStory
Charles River Laboratories (NYSE:CRL) Posts Better-Than-Expected Sales In Q4
February 19, 2025
Lab services company Charles River Laboratories (NYSE:CRL) reported Q4 CY2024 results exceeding the market’s revenue expectations, but sales fell by 1.1% year on year to $1.00 billion. Its non-GAAP...
Via
StockStory
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance
February 19, 2025
From
Charles River Laboratories International, Inc.
Via
Business Wire
Earnings To Watch: Charles River Laboratories (CRL) Reports Q4 Results Tomorrow
February 18, 2025
Lab services company Charles River Laboratories (NYSE:CRL) will be reporting earnings tomorrow before the bell. Here’s what investors should know.
Via
StockStory
Charles River and Deciphex Extend Global Partnership to Expand Digital Pathology Offering with Exclusive Image Management Solutions
February 11, 2025
From
Charles River
Via
Business Wire
Uncover the latest developments among S&P500 stocks in today's session.
February 10, 2025
Curious about the top performers within the S&P500 index in the middle of the day on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Via
Chartmill
Gapping S&P500 stocks in Monday's session
February 10, 2025
Let's have a look at the S&P500 gap up and gap down stocks in today's session.
Via
Chartmill
Charles River Laboratories Schedules Fourth-Quarter 2024 Earnings and 2025 Guidance Release and Conference Call
January 28, 2025
From
Charles River Laboratories International, Inc.
Via
Business Wire
This STMicroelectronics Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday
January 22, 2025
Via
Benzinga
Charles River Expands Apollo™ Ecosystem, Offering Bespoke Client Experiences
January 21, 2025
From
Charles River Laboratories International, Inc.
Via
Business Wire
This Spotify Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
January 17, 2025
Via
Benzinga
Charles River and Akron Bio Announce Collaboration to Enhance Operations with Integration of CGMP Materials into Cell Therapy Platform
January 16, 2025
From
Charles River Laboratories International, Inc.
Via
Business Wire
US Stocks Edge Higher As Traders Eye Inflation Data And Earnings Season Kickoff
January 14, 2025
Wall Street saw a modest uptick on Tuesday as investors turned their focus to upcoming US inflation data following a better-than-expected producer price index (PPI) report.
Via
Talk Markets
Topics
Economy
Stocks / Equities
Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
January 13, 2025
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Introduces Global Biotech Incubator Program
December 05, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories to Present at Evercore ISI Investor Conference
December 02, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories to Present at UBS and Jefferies Conferences
November 11, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Q3 Earnings: CEO Notes Improved Biotech Funding And Stabilizing Demand - Here's Why
November 06, 2024
Charles River Labs Q3 revenue of $1.01 billion surpassed expectations; however, revenue declined 1.6% YoY, and operating margin dropped to 11.6% amid restructuring costs.
Via
Benzinga
S&P 500, Dow Hit Record Highs After Trump Win; Fear Index Drops 20%
November 06, 2024
Market surges to record highs after Trump's election, Republicans win Senate majority. Tech and small-caps up, VIX drops 22%.
Via
Benzinga
Topics
Government
Stocks
Charles River Laboratories Announces Third-Quarter 2024 Results
November 06, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.